ダイトの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/12/22 | 3,290 | 3,290 | 3,235 | 3,245 | -60 | -1.8% | 22,600 |
2017/12/21 | 3,315 | 3,315 | 3,265 | 3,305 | -10 | -0.3% | 21,700 |
2017/12/20 | 3,335 | 3,335 | 3,295 | 3,315 | -30 | -0.9% | 17,400 |
2017/12/19 | 3,430 | 3,430 | 3,340 | 3,345 | -95 | -2.8% | 19,700 |
2017/12/18 | 3,410 | 3,445 | 3,410 | 3,440 | +15 | +0.4% | 15,700 |
2017/12/15 | 3,415 | 3,450 | 3,385 | 3,425 | +10 | +0.3% | 36,200 |
2017/12/14 | 3,320 | 3,420 | 3,320 | 3,415 | +85 | +2.6% | 26,600 |
2017/12/13 | 3,365 | 3,365 | 3,305 | 3,330 | -25 | -0.7% | 22,300 |
2017/12/12 | 3,375 | 3,375 | 3,340 | 3,355 | +10 | +0.3% | 27,300 |
2017/12/11 | 3,260 | 3,370 | 3,260 | 3,345 | +85 | +2.6% | 33,700 |
2017/12/08 | 3,220 | 3,310 | 3,220 | 3,260 | +40 | +1.2% | 48,100 |
2017/12/07 | 3,090 | 3,225 | 3,090 | 3,220 | +110 | +3.5% | 46,100 |
2017/12/06 | 3,105 | 3,215 | 3,095 | 3,110 | -25 | -0.8% | 45,700 |
2017/12/05 | 3,130 | 3,155 | 3,090 | 3,135 | +5 | +0.2% | 23,800 |
2017/12/04 | 3,150 | 3,170 | 3,130 | 3,130 | ±0 | ±0% | 37,600 |
2017/12/01 | 3,105 | 3,155 | 3,090 | 3,130 | +25 | +0.8% | 34,600 |
2017/11/30 | 3,130 | 3,130 | 3,075 | 3,105 | -30 | -1% | 32,800 |
2017/11/29 | 3,090 | 3,240 | 3,090 | 3,135 | +40 | +1.3% | 59,100 |
2017/11/28 | 3,055 | 3,115 | 2,985 | 3,095 | +20 | +0.7% | 45,300 |
2017/11/27 | 3,070 | 3,100 | 3,070 | 3,075 | +15 | +0.5% | 45,700 |
2017/11/24 | 3,030 | 3,070 | 2,990 | 3,060 | +30 | +1% | 30,200 |
2017/11/22 | 2,980 | 3,060 | 2,964 | 3,030 | +65 | +2.2% | 69,500 |
2017/11/21 | 2,980 | 2,992 | 2,939 | 2,965 | +9 | +0.3% | 28,400 |
2017/11/20 | 2,905 | 2,960 | 2,898 | 2,956 | +41 | +1.4% | 20,800 |
2017/11/17 | 2,935 | 2,945 | 2,903 | 2,915 | +4 | +0.1% | 41,100 |
2017/11/16 | 2,874 | 2,940 | 2,872 | 2,911 | +38 | +1.3% | 19,800 |
2017/11/15 | 2,943 | 2,943 | 2,871 | 2,873 | -82 | -2.8% | 30,100 |
2017/11/14 | 2,960 | 2,974 | 2,946 | 2,955 | +7 | +0.2% | 35,100 |
2017/11/13 | 2,912 | 2,966 | 2,882 | 2,948 | +27 | +0.9% | 44,400 |
2017/11/10 | 2,908 | 2,939 | 2,884 | 2,921 | -28 | -0.9% | 33,700 |
2017/11/09 | 2,990 | 3,020 | 2,916 | 2,949 | +1 | ±0% | 55,900 |
2017/11/08 | 3,000 | 3,000 | 2,943 | 2,948 | -67 | -2.2% | 27,100 |
2017/11/07 | 2,971 | 3,020 | 2,949 | 3,015 | +44 | +1.5% | 43,200 |
2017/11/06 | 2,985 | 2,986 | 2,952 | 2,971 | -24 | -0.8% | 34,200 |
2017/11/02 | 2,932 | 3,010 | 2,907 | 2,995 | +63 | +2.1% | 64,200 |
2017/11/01 | 2,905 | 2,936 | 2,877 | 2,932 | +28 | +1% | 29,700 |
2017/10/31 | 2,852 | 2,911 | 2,843 | 2,904 | +21 | +0.7% | 31,500 |
2017/10/30 | 2,900 | 2,912 | 2,868 | 2,883 | -30 | -1% | 41,800 |
2017/10/27 | 2,899 | 2,914 | 2,865 | 2,913 | +38 | +1.3% | 27,900 |
2017/10/26 | 2,901 | 2,902 | 2,848 | 2,875 | -67 | -2.3% | 46,600 |
2017/10/25 | 2,845 | 2,980 | 2,845 | 2,942 | +104 | +3.7% | 113,000 |
2017/10/24 | 2,809 | 2,848 | 2,809 | 2,838 | +22 | +0.8% | 22,300 |
2017/10/23 | 2,790 | 2,826 | 2,766 | 2,816 | +39 | +1.4% | 37,100 |
2017/10/20 | 2,765 | 2,790 | 2,759 | 2,777 | +12 | +0.4% | 29,600 |
2017/10/19 | 2,770 | 2,785 | 2,745 | 2,765 | -11 | -0.4% | 34,500 |
2017/10/18 | 2,760 | 2,785 | 2,737 | 2,776 | +16 | +0.6% | 37,200 |
2017/10/17 | 2,748 | 2,766 | 2,738 | 2,760 | ±0 | ±0% | 28,100 |
2017/10/16 | 2,722 | 2,765 | 2,715 | 2,760 | +39 | +1.4% | 49,300 |
2017/10/13 | 2,713 | 2,724 | 2,665 | 2,721 | -11 | -0.4% | 107,400 |
2017/10/12 | 2,853 | 2,860 | 2,724 | 2,732 | -171 | -5.9% | 112,500 |
1801~
1850
件表示中 / 3704件
類似銘柄と比較する
現在ご覧いただいている「ダイト」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ダイト | 200,500円 | +4.5% | -33.7% | 3.49% | 20.04倍 | 0.58倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ヘリオス | 32,000円 | +150.0% | - | 0.00% | - | 15.74倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
富士製薬 | 125,600円 | +15.7% | +5.3% | 3.62% | 9.08倍 | 0.67倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
ミズホメディ | 149,300円 | +1.2% | -13.9% | 5.69% | 8.80倍 | 1.64倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
扶桑薬 | 225,800円 | +1.6% | -12.7% | 3.99% | 8.38倍 | 0.49倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム